Report cover image

Corneal Edema- Market Insights, Epidemiology, and Market Forecast-2034

Publisher DelveInsight
Published Feb 01, 2024
Length 86 Pages
SKU # DEL19396454

Description

Corneal Edema- Market Insights, Epidemiology, and Market Forecast-2034



United Kingdom, and Japan.

Identifying upcoming solid players in the market will help devise strategies to help get ahead of competitors.

Detailed analysis and ranking of class-wise potential current and emerging therapies under the conjoint analysis section to provide visibility around leading classes.

Highlights of Access and Reimbursement policies for retinal vein occlusion, barriers to accessibility of approved therapy, and patient assistance programs.

To understand Key Opinion Leaders’ perspectives around the accessibility, acceptability, and compliance-related challenges of existing treatment to overcome barriers in the future.

Detailed insights on the unmet needs of the existing market so that the upcoming players can strengthen their development and launch strategy.

Table of Contents

86 Pages
1. Key Insights
2. Report Introduction
3. Corneal Edema Market Overview At A Glance
3.1. Market Share (%) Distribution By Therapies Of Corneal Edema In 2020
3.2. Market Share (%) Distribution By Therapies Of Corneal Edema In 2034
4. Epidemiology And Market Methodology Of Corneal Edema
5. Executive Summary Of Corneal Edema
6. Key Events
7. Corneal Edema: Disease Background And Overview
7.1. Introduction
7.2. Etiology
7.3. Pathophysiology
7.4. Diagnosis
7.4.1. Differential Diagnosis
7.4.2. Diagnostic Algorithm
7.4.3. Diagnostic Guidelines
7.4.3.1. American Academy Of Ophthalmology (Aao) 2018 Guideline For Corneal Edema And Opacification Preferred Practice Pattern
7.5. Management
7.5.1. Treatment Algorithm
7.5.2. Treatment Guidelines
7.5.2.1. Aao 2018 Guideline For Corneal Edema And Opacification Preferred Practice Pattern
8. Epidemiology And Patient Population
8.1. Key Findings
8.2. Assumptions And Rationale
8.2.1. Etiology-specific Diagnosed Prevalent Cases Of Corneal Edema
8.3. The United States
8.3.1. Total Diagnosed Prevalent Cases Of Corneal Edema In The Us
8.3.2. Etiology-specific Diagnosed Prevalent Cases Of Corneal Edema In The Us
9. Patient Journey
10. Emerging Drugs
10.1. Key Cross Competition
10.2. Eo2002: Emmetrope Ophthalmics Llc (“emmecell”)
10.2.1. Product Description
10.2.2. Other Development Activities
10.2.3. Clinical Development
10.2.4. Clinical Trial Information
10.2.5. Safety And Efficacy
10.2.6. Product Profile
10.2.7. Analysts’ Views
10.3. Tthx1114: Trefoil Therapeutics
10.3.1. Product Description
10.3.2. Other Developmental Activities
10.3.3. Clinical Development
10.3.4. Clinical Trials Information
10.3.5. Safety And Efficacy
10.3.6. Product Profile
10.3.7. Analyst Views
10.4. Glanatec (Ripasudil/K-321): D. Western Therapeutics Institute (Dwti)/Kowa Ltd.
10.4.1. Product Description
10.4.2. Other Development Activities
10.4.3. Clinical Development
10.4.4. Clinical Trial Information
10.4.5. Product Profile
10.4.6. Analysts’ Views
10.5. Stn1010904 (Sirolimus)/Ae001: Santen Pharmaceutical/ Actual Eyes
10.5.1. Product Description
10.5.2. Other Developmental Activities
10.5.3. Clinical Development
10.5.4. Clinical Trials Information
10.5.5. Product Profile
10.5.6. Analyst Views
11. Corneal Edema: Market Analysis
11.1. Key Findings
11.2. Market Outlook
11.3. Conjoint Analysis
11.4. Key Market Forecast Assumptions
11.5. Total Market Size Of Corneal Edema In The Us
11.6. Market Size Of Corneal Edema By Therapies In The Us
12. Key Opinion Leaders’ Views
13. Swot Analysis
14. Unmet Needs
15. Market Access And Reimbursement
15.1. The United States
15.1.1. Center For Medicare And Medicaid Services (Cms)
16. Appendix
16.1. Bibliography
16.2. Acronyms And Abbreviations
16.3. Report Methodology
17. Delveinsight Capabilities
18. Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us